{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(1)"],"submitter":["Robinson E"],"pubmed_abstract":["<h4>Background</h4>In 2020, during the COVID-19 pandemic, Médecins Sans Frontières (MSF) initiated three cycles of dihydroartemisin-piperaquine (DHA-PQ) mass drug administration (MDA) for children aged three months to 15 years within Bossangoa sub-prefecture, Central African Republic. Coverage, clinical impact, and community members perspectives were evaluated to inform the use of MDAs in humanitarian emergencies.<h4>Methods</h4>A household survey was undertaken after the MDA focusing on participation, recent illness among eligible children, and household satisfaction. Using routine surveillance data, the reduction during the MDA period compared to the same period of preceding two years in consultations, malaria diagnoses, malaria rapid diagnostic test (RDT) positivity in three MSF communi"],"journal":["Malaria journal"],"pagination":["146"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11094902"],"repository":["biostudies-literature"],"pubmed_title":["Mixed-method evaluation study of a targeted mass drug administration of long-acting anti-malarials among children aged 3 months to 15 years in the Bossangoa sub-prefecture, Ouham, Central African Republic, during the COVID-19 pandemic."],"pmcid":["PMC11094902"],"pubmed_authors":["Sabe SC","Wright R","Sakama NS","Woinzoukou D","Ewers L","Rose L","Stein S","Aboukar EJ","Vyncke J","Gray N","Ouabo A","Van Boetzelaer E","Kuehne A","Serpande C","Rao B","Kpahina OA","van Braak F","Robinson E","Fierte MM"],"additional_accession":[]},"is_claimable":false,"name":"Mixed-method evaluation study of a targeted mass drug administration of long-acting anti-malarials among children aged 3 months to 15 years in the Bossangoa sub-prefecture, Ouham, Central African Republic, during the COVID-19 pandemic.","description":"<h4>Background</h4>In 2020, during the COVID-19 pandemic, Médecins Sans Frontières (MSF) initiated three cycles of dihydroartemisin-piperaquine (DHA-PQ) mass drug administration (MDA) for children aged three months to 15 years within Bossangoa sub-prefecture, Central African Republic. Coverage, clinical impact, and community members perspectives were evaluated to inform the use of MDAs in humanitarian emergencies.<h4>Methods</h4>A household survey was undertaken after the MDA focusing on participation, recent illness among eligible children, and household satisfaction. Using routine surveillance data, the reduction during the MDA period compared to the same period of preceding two years in consultations, malaria diagnoses, malaria rapid diagnostic test (RDT) positivity in three MSF communi","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 May","modification":"2026-07-16T07:33:43.017Z","creation":"2026-07-09T10:44:02.382Z"},"accession":"S-EPMC11094902","cross_references":{"pubmed":["38750517"],"doi":["10.1186/s12936-024-04968-1"]}}